Project Grant K23AA033161
Award Date 8/1/26
Completion Date 7/31/31
Dollars Obligated $212K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Charleston, SC 29425, USA
Similar Awards
- The National Institute on Alcohol Abuse and Alcoholism awarded The Medical University of South Carolina $195,912 on August 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate oleoylethanolamide (OEA) as a therapeutic intervention for alcohol use disorder in young adults. The recipient will conduct a randomized, double-blind, placebo-controlled clinical trial evaluating six weeks of OEA supplementation at 125 milligrams per day in 42 young adults ages 18 to 25 with alcohol...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Medical University of South Carolina $149,190 on March 9, 2026, under the Alcohol Research Programs (CFDA 93.273) to explore the role of medial prefrontal cortex corticotropin-releasing factor circuitry in stress-enhanced alcohol consumption. The research examines how chronic alcohol exposure and chronic stress alter corticotropin-releasing factor (CRF) and CRF receptor 1 (CRFR1) neurons in the prelimbic cortex, a key brain...
- The National Institute on Alcohol Abuse and Alcoholism awarded Duke University $191,443 under the Alcohol Research Programs (CFDA 93.273) on May 1, 2026, to conduct a five-year study examining the proximal relationship between alcohol misuse and suicidal thoughts and behaviors among youth, with focus on executive functioning deficits and interpersonal stress as potential mechanisms of risk. The research will enroll 90 youth participants presenting to two emergency departments in Durham, North...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Medical University of South Carolina $488,077 on September 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate molecular and functional adaptations in the nucleus reuniens, a midline thalamic region implicated in alcohol-related cognitive deficits. The research addresses how chronic alcohol exposure produces cognitive dysfunction that impairs treatment outcomes and increases relapse risk. The project will...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Medical University of South Carolina $151,040 on March 9, 2026, under the Alcohol Research Programs (CFDA 93.273) to investigate orexinergic neuronal circuits and their role in alcohol dependence and excessive ethanol consumption. The project examines functional changes in orexinergic activity in male and female mice following chronic intermittent ethanol exposure, with particular focus on the lateral hypothalamic area-ventral...
- The National Institute on Alcohol Abuse and Alcoholism awarded New York University School of Medicine $2.920164 million on August 1, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and evaluate a precision prevention approach for identifying and addressing behavioral health treatment gaps that drive suicide risk. The project will identify subgroups at highest risk of suicidal thoughts and behaviors, characterize which combinations of mental and substance use disorders place...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Rhode Island $1,403,716 on September 20, 2025, under the Alcohol Research Programs (CFDA 93.273) to examine transactional relationships between sensor-derived alcohol use data and acute suicide risk during community re-entry following residential alcohol use disorder treatment. The research uses ecological momentary assessment and transdermal alcohol sensor technology (BACtrack Skyn) to assess time-varying,...
- The National Institute on Alcohol Abuse and Alcoholism awarded the University of Colorado-Denver $189,532 on August 19, 2026, under the Alcohol Research Programs (CFDA 93.273) to develop and test a peer-narrated video decision aid for alcohol treatment tailored to intensive care unit survivors with alcohol use disorder. The award funds a five-year career development project (K23) led by Dr. Kelsey Hills-Dunlap. The research addresses a gap identified in prior work: ICU survivors with alcohol use...
- The National Institute on Alcohol Abuse and Alcoholism awarded The General Hospital Corporation (Massachusetts General Hospital) $395,079 on September 10, 2025, under the Alcohol Research Programs (CFDA 93.273) for a mentored patient-oriented research career development award. The award funds a study evaluating the feasibility, acceptability, and preliminary clinical utility of measuring dyadic relational processes during early recovery from alcohol use disorder using ecological momentary...
- The National Institute on Alcohol Abuse and Alcoholism awarded The Regents of the University of California, San Francisco $203,036 on July 9, 2026, under the Alcohol Research Programs (CFDA 93.273) to support a mentored patient-oriented research career development project (K23) led by Dr. Natalia Van Doren. The award funds a mobile mindfulness-based intervention for unhealthy alcohol use in people with anxiety, combining integrated training and research activities. Dr. Van Doren will receive...